Academician profile · PROFESÖR
ALİ DURSUN
- TIP FAKÜLTESİ
- DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
Scopus (SJR)
Q1
27
Q2
30
Q3
16
Q4
3
WoS (JCR)
Q1
17
Q2
20
Q3
24
Q4
15
TR Index
13
articles
Articles
- 2025 Comparison of Ketogenesis and Ketolysis Defects: A Retrospective Single-Center Study of 30 Patients
- 2025 Endoplasmic reticulum stress pathways and cellular death mechanisms in patients with phenylketonuria
- 2025 Clinical and laboratory characteristics of propionic acidemia in a Turkish cohort
- 2025 Metabolomics and Lipidomics Explore Phenotype-Specific Molecular Signatures for Phenylketonuria
- 2025 Phenotypic diversity in NAXE mutations
- 2025 High prevalence of low bone mineral density in young adults with phenylketonuria
- 2025 Comprehensive analysis of 1103 infants referred to a single center due to positive newborn screening test for phenylketonuria
- 2024 Long-term clinical evaluation of patients with alpha-mannosidosis – A multicenter study
- 2024 ELFN1 is a new extracellular matrix (ECM)-associated protein
- 2024 High prevalence of low bone mineral density in young adults with phenylketonuria
- 2024 A transposase-derived gene required for human brain development
- 2024 Exploring metabolic alterations in PYCR2 deficiency: Unveiling pathways and clinical presentations of hypomyelinating leukodystrophy 10
- 2024 Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?
- 2024 Longitudinal Dietary Intake Data in Patients with Phenylketonuria from Europe: The Impact of Age and Phenylketonuria Severity
- 2024 From Shadows to Diagnosis: Unraveling L-2 Hydroxyglutaric Aciduria in Adulthood
- 2024 Long-term clinical evaluation of patients with alpha-mannosidosis - A multicenter study
- 2024 ELFN1 is a new extracellular matrix (ECM)-associated protein
- 2023 COVID-19 in inherited metabolic disorders: Clinical features and risk factors for disease severity
- 2023 Predictors of eventual requirement of phenylalanine-restricted diet in young infants with phenylalanine hydroxylase deficiency initially managed with sapropterin monotherapy
- 2022 Single Institutional Experience with GM1 Gangliosidosis: Clinical and Laboratory Results of 14 Patients